1. Salmi H, Heinonen S, Hästbacka J, Lääperi M, Rautiainen P, Miettinen PJ, et al. New-onset type 1 diabetes in Finnish children during the COVID-19 pandemic. Arch Dis Child. 2022; 107:180–5.
3. Knip M, Simell O. Environmental triggers of type 1 diabetes. Cold Spring Harb Perspect Med. 2012; 2:a007690.
4. Prosperi S, Chiarelli F. COVID-19 and diabetes in children. Ann Pediatr Endocrinol Metab. 2022; 27:157–68.
5. Unsworth R, Wallace S, Oliver NS, Yeung S, Kshirsagar A, Naidu H, et al. New-onset type 1 diabetes in children during COVID-19: Multicentre regional findings in the U.K. Diabetes Care. 2020; 43:e170–1.
6. García Romero R, Baleta Riera L, Sanz Marcos N, Arias Constanti V, Trenchs Sainz de la Maza V, Luaces C. Newonset type 1 diabetes mellitus in the Paediatric Emergency Department: impact of the COVID-19 pandemic. Ann Pediatr Endocrinol Metab. 2023; 28:215–8.
7. D'Souza D, Empringham J, Pechlivanoglou P, Uleryk EM, Cohen E, Shulman R. Incidence of diabetes in children and adolescents during the COVID-19 pandemic: a systematic review and meta-analysis. JAMA Netw Open. 2023; 6:e2321281.
8. Rahmati M, Keshvari M, Mirnasuri S, Yon DK, Lee SW, Il Shin J, et al. The global impact of COVID-19 pandemic on the incidence of pediatric new-onset type 1 diabetes and ketoacidosis: a systematic review and meta-analysis. J Med Virol. 2022; 94:5112–27.
9. Rewers M, Ludvigsson J. Environmental risk factors for type 1 diabetes. Lancet. 2016; 387:2340–8.
10. Alfayez OM, Aldmasi KS, Alruwais NH, Bin Awad NM, Al Yami MS, Almohammed OA, et al. Incidence of diabetic ketoacidosis among pediatrics with type 1 diabetes prior to and during COVID-19 pandemic: a meta-analysis of observational studies. Front Endocrinol (Lausanne). 2022; 13:856958.